Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Specials
Spring Home & Garden Show
Home & Realty
Outdoor Guide
Women
Spring on the Road
Spring Wellness
Premier Home Stylle Tour 2024
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
2024 Readersâ Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Cyclo Therapeutics Inc
(NQ:
CYTH
)
0.7216
-0.0264 (-3.53%)
Streaming Delayed Price
Updated: 3:37 PM EDT, Nov 1, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Cyclo Therapeutics Inc
< Previous
1
2
3
4
5
6
Next >
Cyclo Therapeutics Announces Allowance of Patent from European Patent Office for Trappsol® Cyclo™ for Alzheimer’s Disease
June 12, 2023
From
Cyclo Therapeutics, Inc.
Via
Business Wire
Cyclo Therapeutics Announces Execution of Definitive Agreement with Rafael Holdings, Inc. Providing for $5.0 Million of Additional Funding Via a Private Placement
June 05, 2023
From
Cyclo Therapeutics, Inc.
Via
Business Wire
Cyclo Therapeutics Provides Business Update and Reports First Quarter 2023 Financial Results
May 15, 2023
From
Cyclo Therapeutics, Inc.
Via
Business Wire
Cyclo Therapeutics's Return On Capital Employed Insights
March 21, 2023
Via
Benzinga
Cyclo Therapeutics Announces Closing of Strategic Investment Through a $2.1 Million Private Placement from Rafael Holdings, Inc. (NYSE:RFL)
May 02, 2023
From
Cyclo Therapeutics, Inc.
Via
Business Wire
Why Bed Bath & Beyond Shares Are Trading Lower By 23%; Here Are 20 Stocks Moving Premarket
April 26, 2023
Gainers
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
April 21, 2023
Via
Benzinga
Why GE HealthCare Technologies Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
April 25, 2023
Gainers
Via
Benzinga
Cyclo Therapeutics Announces Closing of $1.3 Million Private Placement Priced At-The-Market Under Nasdaq Rules
April 21, 2023
From
Cyclo Therapeutics, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
April 12, 2023
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
April 07, 2023
Via
Benzinga
Stocks That Hit 52-Week Lows On Monday
April 03, 2023
On Monday, 76 companies set new 52-week lows.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 21, 2023
March 21, 2023
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
March 20, 2023
Via
Benzinga
Cyclo Therapeutics Provides Business Update and Reports Full Year 2022 Financial Results
March 20, 2023
From
Cyclo Therapeutics
Via
Business Wire
Why Universal Electronics Shares Are Trading Lower By 30%? Here Are Other Stocks Moving In Friday's Mid-Day Session
February 17, 2023
Gainers Ibio Inc (NYSE: IBIO) shares rose 97% to $1.4787 after the company announced MUC16 as its latest immune-oncology target program.
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
February 16, 2023
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
January 18, 2023
Via
Benzinga
JTC Team to Host the Virtual Investor 2023 Companies to Watch Event on January 17th, 18th, and 19th
January 11, 2023
Via
ACCESSWIRE
Cyclo Therapeutics Provides Clinical Program Update and Highlights Recent Achievements
January 11, 2023
From
Cyclo Therapeutics, Inc.
Via
Business Wire
Cyclo Therapeutics to Present at the Virtual Investor 2023 Companies to Watch Event
January 10, 2023
From
Cyclo Therapeutics, Inc.
Via
Business Wire
Cyclo Therapeutics Announces First Patient Dosed in Phase 2b Study of Trappsol® Cyclo™ for the Treatment of Early Alzheimer’s Disease
January 09, 2023
From
Cyclo Therapeutics, Inc.
Via
Business Wire
Cyclo Therapeutics Announces Closing of $4.2 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
January 04, 2023
From
Cyclo Therapeutics, Inc.
Via
Business Wire
Cyclo Therapeutics Announces Abstract Accepted for Poster Presentation at the Society for Inherited Metabolic Disorders (SIMD) 44th Annual Meeting
January 04, 2023
From
Cyclo Therapeutics, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Monday's Pre-Market Session
January 02, 2023
Via
Benzinga
Cyclo Therapeutics Announces $4.2 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
December 30, 2022
From
Cyclo Therapeutics, Inc.
Via
Business Wire
Why Cracker Barrel Shares Are Trading Lower By Around 13%? Here Are 42 Stocks Moving In Friday's Mid-Day Session
December 02, 2022
Gainers Yunhong CTI Ltd. (NASDAQ: CTIB) rose 42% to $0.54 after dipping 56% on Thursday.
Via
Benzinga
Why Coupa Software Shares Jumped Around 29%; Here Are 72 Biggest Movers From Wednesday
November 25, 2022
Gainers Kalera Public Limited Company (NASDAQ: KAL) jumped 76.9% to close at $0.1610 on Wednesday after gaining 9% on Tuesday. Kalera recently posted a Q3 loss of $0.05 per share.
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
November 24, 2022
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
November 21, 2022
Via
Benzinga
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.